Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$181.58 - $368.0 $11.7 Million - $23.6 Million
-64,250 Reduced 43.95%
81,933 $15.1 Million
Q1 2022

Apr 28, 2022

SELL
$303.87 - $423.8 $15.9 Million - $22.1 Million
-52,176 Reduced 26.3%
146,183 $51.1 Million
Q4 2021

Jan 24, 2022

BUY
$347.28 - $421.83 $4.51 Million - $5.47 Million
12,973 Added 7.0%
198,359 $75.5 Million
Q3 2021

Oct 28, 2021

BUY
$405.61 - $524.84 $1.97 Million - $2.55 Million
4,851 Added 2.69%
185,386 $75.1 Million
Q2 2021

Jul 28, 2021

SELL
$372.84 - $481.5 $8.44 Million - $10.9 Million
-22,632 Reduced 11.14%
180,535 $85.4 Million
Q1 2021

May 07, 2021

BUY
$361.28 - $504.76 $5.22 Million - $7.29 Million
14,438 Added 7.65%
203,167 $78 Million
Q4 2020

Jan 25, 2021

BUY
$292.7 - $370.96 $3.02 Million - $3.82 Million
10,308 Added 5.78%
188,729 $69.8 Million
Q3 2020

Oct 30, 2020

SELL
$268.51 - $400.74 $1.46 Million - $2.18 Million
-5,439 Reduced 2.96%
178,421 $55.1 Million
Q2 2020

Aug 06, 2020

SELL
$256.46 - $373.01 $3.86 Million - $5.61 Million
-15,034 Reduced 7.56%
183,860 $68 Million
Q1 2020

Apr 30, 2020

BUY
$209.2 - $335.53 $5.35 Million - $8.58 Million
25,570 Added 14.75%
198,894 $54.3 Million
Q4 2019

Jan 21, 2020

SELL
$288.29 - $335.49 $196,902 - $229,139
-683 Reduced 0.39%
173,324 $57.5 Million
Q3 2019

Oct 21, 2019

BUY
$266.84 - $378.23 $3 Million - $4.25 Million
11,241 Added 6.91%
174,007 $52.9 Million
Q2 2019

Jul 09, 2019

BUY
$300.59 - $368.15 $18.1 Million - $22.2 Million
60,287 Added 58.83%
162,766 $59.9 Million
Q1 2019

Apr 10, 2019

BUY
$272.57 - $321.18 $26 Million - $30.7 Million
95,503 Added 1369.02%
102,479 $31.8 Million
Q4 2018

Jan 14, 2019

BUY
$272.46 - $366.54 $1.9 Million - $2.56 Million
6,976 New
6,976 $2.09 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $12.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Aegon Asset Management Uk PLC Portfolio

Follow Aegon Asset Management Uk PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.